NCT02183025View on ClinicalTrials.gov

Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea

PHASE2CompletedINTERVENTIONAL
Enrollment

337

Participants

Timeline

Start Date

January 31, 1998

Primary Completion Date

April 30, 1999

Conditions
Dysmenorrhea
Interventions
DRUG

Meloxicam 7.5 mg

DRUG

Meloxicam 15 mg

DRUG

Mefenamic acid 500 mg

DRUG

Placebo matching 7.5 mg meloxicam

DRUG

Placebo matching 15 mg meloxicam

DRUG

Placebo matching 500 mg mefenamic acid

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY